Orexo
ORX | ST
Overview
Corporate Details
- ISIN(s):
- SE0000736415 (+2 more)
- LEI:
- 549300LJ5CCWDPTK9Z08
- Country:
- Sweden
- Address:
- Box 303, 751 05 UPPSALA
- Website:
- https://orexo.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Orexo is a commercial-stage specialty pharmaceutical company that develops and commercializes improved pharmaceuticals based on proprietary and innovative drug delivery technologies. The company primarily focuses on addressing unmet medical needs in therapeutic areas such as opioid use disorder (OUD) and pain management. Its key commercialized product is Zubsolv®, a treatment for OUD. With over 30 years of experience, Orexo manages the entire product lifecycle from research and development to commercialization, maintaining a significant presence in the US market.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Orexo.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-16 08:00 |
Interim Report
|
Swedish | 6.7 MB | |
| 2025-07-16 08:00 |
Interim Report
|
English | 6.6 MB | |
| 2025-06-30 17:30 |
Declaration of Voting Results & Voting Rights Announcements
Antal aktier och röster i Orexo
|
Swedish | 76.3 KB | |
| 2025-06-30 17:30 |
Declaration of Voting Results & Voting Rights Announcements
Number of shares and votes in Orexo
|
English | 76.6 KB | |
| 2025-06-25 11:38 |
Major Shareholding Notification
|
Swedish | 9.8 KB | |
| 2025-06-19 16:40 |
Major Shareholding Notification
|
Swedish | 9.9 KB | |
| 2025-06-18 18:00 |
Share Issue/Capital Change
Emission och återköp av C-aktier
|
Swedish | 166.4 KB | |
| 2025-06-18 18:00 |
Share Issue/Capital Change
Issue and repurchase of class C shares
|
English | 168.1 KB | |
| 2025-05-08 17:15 |
Post-Annual General Meeting Information
Report from Orexo AB’s annual general meeting 8 May 2025
|
English | 175.7 KB | |
| 2025-05-08 17:15 |
Post-Annual General Meeting Information
Kommuniké från Orexo AB:s årsstämma den 8 maj 2025
|
Swedish | 148.7 KB | |
| 2025-05-06 08:00 |
Quarterly Report
|
Swedish | 4.6 MB | |
| 2025-05-06 08:00 |
Interim Report
|
English | 4.6 MB | |
| 2025-02-06 08:00 |
Regulatory News Service
|
Swedish | 5.3 MB | |
| 2025-02-06 08:00 |
Annual / Quarterly Financial Statement
|
English | 5.3 MB | |
| 2024-12-18 11:45 |
Post-Annual General Meeting Information
Kommuniké från Orexo AB:s extra bolagsstämma den 18 december 2024
|
Swedish | 124.4 KB |
Automate Your Workflow. Get a real-time feed of all Orexo filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Orexo via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-11 | Nikolaj Arrild Sørensen | Other | Buy | 2,460 | 35,178.00 SEK |
| 2025-04-04 | Nikolaj Arrild Sørensen | Other | Buy | 3,500 | 47,530.00 SEK |
| 2024-03-26 | Fredrik Järrsten | Other | Buy | 3,000 | 44,040.00 SEK |
| 2023-11-24 | Charlotte Vithlani Hansson | Other | Buy | 3,000 | 44,640.00 SEK |
| 2023-11-08 | Fredrik Järrsten | Other | Buy | 1,500 | 23,715.00 SEK |
| 2023-02-24 | Nikolaj Arrild Sørensen | Other | Buy | 11,500 | 188,945.00 SEK |
| 2023-01-27 | Fredrik Järrsten | Other | Buy | 4,500 | 79,695.00 SEK |
| 2022-07-26 | Michael Matly | Other | Buy | 2,820 | 60,777.77 SEK |
| 2022-07-21 | Charlotte Vithlani Hansson | Other | Buy | 3,000 | 61,500.00 SEK |
| 2022-07-15 | James Noble | Other | Buy | 18,500 | 394,252.80 SEK |
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
